• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性重度溃疡性结肠炎:内科和急诊医师的管理建议。

Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians.

机构信息

Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, St James University Hospital, Bexley Wing, Leeds, LS9 7TF, UK.

University of Leeds, Leeds, UK.

出版信息

Intern Emerg Med. 2021 Sep;16(6):1433-1442. doi: 10.1007/s11739-021-02704-0. Epub 2021 Mar 22.

DOI:10.1007/s11739-021-02704-0
PMID:33754227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8354863/
Abstract

Acute severe ulcerative colitis is a medical emergency that warrants in-patient management. This is best served within a multidisciplinary team setting in specialised centres or with expert consultation. Intravenous corticosteroids remain the cornerstone in the management of ASUC and should be initiated promptly, along with general management measures and close monitoring of patients. Unfortunately, one-third of patients will fail to respond to steroids. Response to intravenous corticosteroid therapy needs to be assessed on the third day and rescue therapies, including cyclosporine and infliximab, should be offered to patients not responding. Choice of rescue therapy depends on experience, drug availability and factors associated with each individual patient, such as comorbidities, previous medications or contra-indications to therapy. Patients who have not responded within 7 days to rescue therapy must be considered for surgery. Surgery is a treatment option in ASUC and should not be delayed in cases of failure of medical therapy, because such delays increase surgical morbidity and mortality. This review summarises the current management of acute severe ulcerative colitis and discusses potential future developments.

摘要

急性重度溃疡性结肠炎是一种医疗急症,需要住院治疗。最好在多学科团队的专业中心进行治疗,或者寻求专家咨询。静脉注射皮质类固醇仍然是治疗重度溃疡性结肠炎的基石,应尽快启动,并同时进行一般治疗措施和密切监测患者。不幸的是,三分之一的患者对类固醇治疗无反应。应在第 3 天评估静脉注射皮质类固醇治疗的反应,并为未反应的患者提供环孢素和英夫利昔单抗等抢救治疗。抢救治疗的选择取决于经验、药物可用性以及与每位患者相关的因素,如合并症、先前的药物治疗或治疗的禁忌症。对于在 7 天内未对抢救治疗有反应的患者,必须考虑手术治疗。手术是急性重度溃疡性结肠炎的一种治疗选择,不应因药物治疗失败而延迟手术,因为此类延迟会增加手术发病率和死亡率。本综述总结了急性重度溃疡性结肠炎的当前治疗方法,并讨论了潜在的未来发展。

相似文献

1
Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians.急性重度溃疡性结肠炎:内科和急诊医师的管理建议。
Intern Emerg Med. 2021 Sep;16(6):1433-1442. doi: 10.1007/s11739-021-02704-0. Epub 2021 Mar 22.
2
Optimal management of acute severe ulcerative colitis.急性重度溃疡性结肠炎的最佳治疗方案。
Postgrad Med J. 2019 Jan;95(1119):32-40. doi: 10.1136/postgradmedj-2018-136072. Epub 2019 Jan 12.
3
Surgical and medical treatment in patients with acute severe ulcerative colitis.急性重症溃疡性结肠炎患者的手术及内科治疗
J Dig Dis. 2015 Oct;16(10):558-67. doi: 10.1111/1751-2980.12278.
4
Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies.在使用皮质类固醇治疗失败的早期预测指标和挽救疗法时,急性重症溃疡性结肠炎的预后得到改善。
Dig Liver Dis. 2016 Jun;48(6):608-12. doi: 10.1016/j.dld.2016.02.024. Epub 2016 Mar 5.
5
Acute Severe Ulcerative Colitis: Optimal Strategies for Drug Therapy.急性重度溃疡性结肠炎:药物治疗的最佳策略。
Gut Liver. 2023 Jan 15;17(1):49-57. doi: 10.5009/gnl220017. Epub 2022 Nov 14.
6
Management of acute severe ulcerative colitis-an update for generalist and specialist clinicians.急性重度溃疡性结肠炎的管理:对全科医生和专科医生的最新更新。
Br Med Bull. 2024 Sep 27;151(1):3-15. doi: 10.1093/bmb/ldae006.
7
Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review.类固醇难治性急性重度溃疡性结肠炎的抢救治疗:综述。
J Crohns Colitis. 2023 Jun 16;17(6):972-994. doi: 10.1093/ecco-jcc/jjad004.
8
Algorithm for managing severe ulcerative colitis.重度溃疡性结肠炎的管理算法。
Trop Gastroenterol. 2014 Aug;35 Suppl 1:S40-4. doi: 10.7869/tg.182.
9
Review article: the practical management of acute severe ulcerative colitis.综述文章:急性重症溃疡性结肠炎的实际管理
Aliment Pharmacol Ther. 2016 Feb;43(4):482-513. doi: 10.1111/apt.13491. Epub 2016 Jan 4.
10
Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.不同抢救疗法在急性、重度、激素抵抗性溃疡性结肠炎中的保肛能力。
Expert Rev Gastroenterol Hepatol. 2014 Aug;8(6):695-702. doi: 10.1586/17474124.2014.909726. Epub 2014 Apr 17.

引用本文的文献

1
Recent Advances in the Management of Acute Severe Ulcerative Colitis.急性重症溃疡性结肠炎治疗的最新进展
J Clin Med. 2024 Dec 6;13(23):7446. doi: 10.3390/jcm13237446.
2
Efficacy and safety of Xileisan combined with mesalazine for ulcerative colitis: A meta-analysis and trial sequential analysis.锡类散联合美沙拉嗪治疗溃疡性结肠炎的疗效与安全性:一项Meta分析和试验序贯分析
World J Clin Cases. 2024 Jul 26;12(21):4703-4716. doi: 10.12998/wjcc.v12.i21.4703.
3
3D printed multi-drug-loaded suppositories for acute severe ulcerative colitis.用于急性重症溃疡性结肠炎的3D打印多药负载栓剂
Int J Pharm X. 2023 Jan 29;5:100165. doi: 10.1016/j.ijpx.2023.100165. eCollection 2023 Dec.
4
Evidence-based pathogenesis and treatment of ulcerative colitis: A causal role for colonic epithelial hydrogen peroxide.基于证据的溃疡性结肠炎发病机制和治疗:结肠上皮过氧化氢的因果作用。
World J Gastroenterol. 2022 Aug 21;28(31):4263-4298. doi: 10.3748/wjg.v28.i31.4263.
5
Acute severe ulcerative colitis: management advice for internal medicine and emergency physicians-comment.
Intern Emerg Med. 2021 Nov;16(8):2323. doi: 10.1007/s11739-021-02739-3. Epub 2021 Apr 19.

本文引用的文献

1
An approach to acute severe ulcerative colitis.急性重度溃疡性结肠炎的治疗方法。
Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):943-955. doi: 10.1080/17474124.2019.1681974. Epub 2019 Oct 30.
2
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.英国胃肠病学会成人炎症性肠病管理共识指南。
Gut. 2019 Dec;68(Suppl 3):s1-s106. doi: 10.1136/gutjnl-2019-318484. Epub 2019 Sep 27.
3
Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial.一项关于白细胞介素 1 阻断在急性重度结肠炎中的 II 期随机安慰剂对照双盲试验的试验总结和方案:IASO 试验。
BMJ Open. 2019 Feb 15;9(2):e023765. doi: 10.1136/bmjopen-2018-023765.
4
Optimal management of acute severe ulcerative colitis.急性重度溃疡性结肠炎的最佳治疗方案。
Postgrad Med J. 2019 Jan;95(1119):32-40. doi: 10.1136/postgradmedj-2018-136072. Epub 2019 Jan 12.
5
Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis.4 例急性重度溃疡性结肠炎患者应用高强度托法替布诱导治疗的疗效。
Clin Gastroenterol Hepatol. 2019 Apr;17(5):988-990.e1. doi: 10.1016/j.cgh.2018.11.022. Epub 2018 Nov 17.
6
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.钙调磷酸酶抑制剂联合维得利珠单抗诱导治疗在难治性溃疡性结肠炎患者中的疗效和安全性。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):494-501. doi: 10.1016/j.cgh.2018.08.081. Epub 2018 Sep 10.
7
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis.托法替尼诱导治疗可在 3 天内减轻溃疡性结肠炎患者的症状。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):139-147. doi: 10.1016/j.cgh.2018.07.009. Epub 2018 Sep 10.
8
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.钙调磷酸酶抑制剂联合维得利珠单抗治疗难治性炎症性肠病的安全性和疗效。
Clin Gastroenterol Hepatol. 2019 Feb;17(3):486-493. doi: 10.1016/j.cgh.2018.04.060. Epub 2018 May 8.
9
Faecal Calprotectin and UCEIS Predict Short-term Outcomes in Acute Severe Colitis: Prospective Cohort Study.粪便钙卫蛋白和 UCEIS 预测急性重度结肠炎的短期结局:前瞻性队列研究。
J Crohns Colitis. 2017 Oct 27;11(11):1309-1316. doi: 10.1093/ecco-jcc/jjx084.
10
Predictors of emergency colectomy in patients admitted with acute severe ulcerative colitis.急性重症溃疡性结肠炎入院患者急诊结肠切除术的预测因素。
S Afr J Surg. 2017 Sep;55(3):20-26.